Rise and Shine: What you need to know before the ASX opens
Link copied to
On Stockhead today, new tech is helping stomp out rising gold fraud, Botanix is using synthetic cannabinoids to treat acne and other skin conditions, and COVID-19 testing will last for ‘several years not several months’.
In today’s economic data there’s June building approvals from the ABS, along with Q2 trade figures. Key data abroad will be led by Q2 GDP figures out of the US, along with the weekly print for initial jobless claims.
The following companies are in trading halts and are expected to exit in the next two trading days:
Prominence Energy (ASX:PRM) – capital raising
Predictive Discovery (ASX:PDI) – drilling results
Metal Bank (ASX:MBK) – capital raising
Carnavale Resources (ASX:CAV) – project acquisition
Redflow (ASX:RFX) – capital raising update
Nuchev (ASX:NUC) – capital raising
Cobalt Blue Holdings (ASX:COB) – capital raising
Eastern Iron (ASX:EFE) – capital raising
Gold: $US1,970.50 ($2,741.69) (+0.59%)
Silver: $US24.28 (+0.38%)
Oil (WTI): $US41.31 (+0.58%)
Oil (Brent): $US43.80 (+1.34%)
Coal: $US52.33 (-0.89%)
Iron 62pc Fe: $US107.72 (+0.24%)
AUD/USD: $US0.7187 (+0.41%)
Bitcoin: $US11,221.08 (+2.82%)
Yesterday saw the focus returned to cannabis, and what listed players in the space have to do to be successful.
Elsewhere, Stockhead’s resident guru Dr Nigel Finch spoke to three industry experts about whether the recent price action in ASX tech stocks is reminiscent of a ‘Tech Bubble 2.0’.
Also, be sure to check in at 10.20am each morning for our daily 10 at 10 column — a live summary of winners & losers at the opening bell.